Related Experiment Videos
[The effect of thrombocyte-derived growth factor on experimental inflammatory bowel disease]
Z Sándor1, S Kusstatscher, D Szeli
1Department of Pathology Brigham Women's Hospital Harvard Medical School, Boston, USA.
Orvosi Hetilap
|May 14, 1995
Abstract:
The role of Platelet-Derived Growth Factor (PDGF) was investigated in treatment of experimental inflammatory bowel disease (IBD) in animal models. A new model of IBD induced by the sulfhydryl (SH) alkylator iodoacetamide revealed that the most appropriate concentration of iodoacetamide is 6% given intracolonically once. Daily treatment with PDGF dose-dependently accelerated the healing of colonic erosions, ulcers and inflammation.